Advertisement

Effects of cytokines on human EEG and sleep

  • J. Born
  • E. Späth-Schwalbe
Part of the Key Topics in Brain Research book series (KEYTOPICS)

Abstract

Numerous experiments in animals have indicated a mutual interdependency between central nervous sleep/wake processes and immunological functions (Krüger et al., 1990; Krüger and Karnovsky, 1995; Toth, 1995). Two principally different concepts have guided this research. On the one hand, it was assumed that sleep has a general restoring effect, and in this context also facilitates immune functioning (e.g., Dinges etal., 1994; Born etal., 1997). On the other hand, the hypothesis has been put forward that the immune system influences sleep. Support for this latter view derived from common observations that infectious diseases may be accompanied by intense feelings of tiredness and sleepiness. Immune processes may induce and maintain central nervous sleep via the release of cytokines which are the messengers of the immune system. In animals, especially cytokines initiating the immune response such as the monocyte/macrophage derived cytokines tumor necrosis factor-a (TNF-a) and interleukin-1 (IL-1) but also interferons (IFNs) have been shown to facilitate sleep (e.g., Shoham etal., 1987; Kriiger etal., 1984, 1987, 1990). This paper concentrates on studies examining whether proinflammatory cytokines exert a similar promoting effect on human sleep.

Keywords

Thyroid Stimulate Hormone Acute Phase Response Thyroid Stimulate Hormone Level Thyroid Stimulate Hormone Concentration Adjective Check List 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4: 2860 – 2867PubMedGoogle Scholar
  2. Alford FP, Baker HW, Burger HG, de Kretser DM, Hudson B, Johns MW, Masterson JP (1973) Temporal patterns of integrated plasma hormone levels during sleep and wakefulness. J Clin Endocrinol Metab 37: 841 – 847PubMedCrossRefGoogle Scholar
  3. Appelberg B, Katila H, Rimon R (1997) Plasma interleukin-1βand sleep architecture in schizophrenia and other non-affective psychoses. Psychosom Med 59: 529 – 532PubMedGoogle Scholar
  4. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15: 74 – 80PubMedCrossRefGoogle Scholar
  5. Born J, Späth-Schwalbe E, Pietrowsky R, Porzsolt F, Fehm HL (1989) Neurophysiological effects of recombinant interferon-gamma and alpha in man. Clin Physiol Biochem 7: 119 – 127PubMedGoogle Scholar
  6. Born J, Späth-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL (1989) Influences of corticotropin-releasing hormone, adrenocorticotropin, and Cortisol on sleep in normal man. J Clin Endocrinol Metab 68: 904 – 911PubMedCrossRefGoogle Scholar
  7. Born J, Bathelt B, Pietrowsky R, Pauschinger P, Fehm HL (1990) Influences of peripheral adrenocorticotropin 1–39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP). Psychopharmacol 101: 34 – 38CrossRefGoogle Scholar
  8. Born J, Lange T, Hansen K, Mölle M, Fehm HL (1997) Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 158: 4454 – 4464PubMedGoogle Scholar
  9. Brabant G, Brabant A, Ranft U, Ocran K, Köhrle J, Hesch RD, von zur Muhlen A (1987) Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab 65: 83 – 88PubMedCrossRefGoogle Scholar
  10. Brightman MW, Prescott L, Reese TS (1975) Intercellular junctions of special epen- dyma. In: Knigge S, Scott WT, Kobayashi Y, Ishii Y (eds) Brain endocrine inter-action. Karger, Basel, pp 146 – 165Google Scholar
  11. Bunnell DE, Horvath SM (1985) Effects of body heating during sleep interruption. Sleep 8: 274 – 282PubMedGoogle Scholar
  12. Cajochen C, Dijk DJ, Borbély AA (1992) Dynamics of EEG slow wave activity and core body temperature in human sleep after exposure to bright light. Sleep 15: 337 – 343PubMedGoogle Scholar
  13. Calvet M, Gresser I (1979) Interferon enhances the excitability of cultured neurons. Nature 278: 558 – 560PubMedCrossRefGoogle Scholar
  14. Dinges DF, Douglas SD, Zaugg L, Campbell DE, McMann JM, Whitehouse WG, Orne EC, Kapoor SC, Icaza E, Orne MT (1994) Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest 93: 1930 – 1939PubMedCrossRefGoogle Scholar
  15. Gameren MM, Willemse PHB, Mulder NH, Limburg PC, Groen HJM, Vellenga E, de Vries EGE (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84: 1434 – 1441PubMedGoogle Scholar
  16. Ganguli R, Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS (1993) Au-toimmunity in schizophrenia: a review of recent findings. Ann Med 25: 489 – 496PubMedCrossRefGoogle Scholar
  17. Habif DV, Lipton R, Cantell K (1975) Interferon crosses blood-cerebrospinal fluid barrier in monkeys. Proc Soc Exp Biol Med 149: 287 – 289PubMedGoogle Scholar
  18. Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical aspects of interleukin 6. Immunol Today 11: 443 – 449PubMedCrossRefGoogle Scholar
  19. Honre JA, Moore VJ (1985) Sleep effects of exercise with and without additional body cooling. Electroencephalogr Clin Neurophysiol 60: 33 – 38CrossRefGoogle Scholar
  20. Honre JA, Reid AJ (1985) Night-time sleep EEG changes following body heating in a warm bath. Electroencephalogr Clin Neurophysiol 60: 154 – 157CrossRefGoogle Scholar
  21. Janke W, Debus G (1978) Die Eigenschaftswörterliste EWL. Eine mehrdimensionale Methode zur Beschreibung von Aspekten des Befindens. Hogrefe, GöttingenGoogle Scholar
  22. Kales A, Heuser G, Jacobson A, Kales JD, Hanley J, Zweizig JR, Paulson MJ (1967) All night sleep studies in hypothyroid patients, before and after treatment. J Clin Endocrinol Metab 27: 1593 – 1599PubMedCrossRefGoogle Scholar
  23. Kishimoto T (1989) The biology of interleukin-6. Blood 74: 1 – 10PubMedGoogle Scholar
  24. Krüger JM, Karnovsky ML (1995) Sleep as a neuroimmune phenomenon: a brief historical perspective. Adv Neuroimmunol 5: 5 – 12CrossRefGoogle Scholar
  25. Krüger JM, Walter J, Dianrello CA, Wolff SM, Chedid L (1984) Sleep-promoting effects of endogenous pyrogen. Am J Physiol 246: R994 – 999Google Scholar
  26. Krüger JM, Dinarello CA, Shoham S, Davenne D, Wilter J, Kubillus S (1987) Interferon alpha-2 enhances slow-wave sleep in rabbits. Int J Immunopharmacol 9: 23 – 30CrossRefGoogle Scholar
  27. Krüger JM, Obal F, Opp L, Toth L, Johannsen L, Cady AB (1990) Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med 106: 97 – 100Google Scholar
  28. Le JM, Fredrickson G, Reis LFL, Diamantsein T, Hirano T, Kishimoto T, Vilcek J (1988) Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin-6. Proc Natl Acad Sci IJSA 85: 8643 – 8647CrossRefGoogle Scholar
  29. Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77: 1690 – 1694PubMedCrossRefGoogle Scholar
  30. Mattson K, Niiranen A, Iivanainen M, Färkkila M, Bergstrom L, Holsti LR, Kauppinen HL, Cantell K (1983) Neurotoxicity of interferon. Cancer Treat Rep 67: 958 – 961PubMedGoogle Scholar
  31. Mattson K, Holsti LR, Niiranen A, Pyrhonen S, Farkkila M, Hartel G, Standertskiölt-Nordenstam CG, Cantell K (1987) Comparison of clinical toxicity of natural alpha and recombinant gamma interferon. In: Cantell ST, Schellekens V (eds) The biology of interferon system 1986. Nijhoff, DordrechtGoogle Scholar
  32. Naitoh Y, Fukata J, Tominaga T, Nakai T, Tamai S, Mori K, Imura H (1988) Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in con¬scious, freely-moving rats. Biochem Biophys Res Commun 155: 1459 – 1463PubMedCrossRefGoogle Scholar
  33. Nakazawa Y, Kotorii T, Horikawa S, Kororii M, Ohshima M, Hasuzawa H (1979) Individual variations in the effects of flurazepam, clorazepate, L-dopa and thyrotropin-releasing hormone on REM sleep in man. Psychopharmacology 60: 203 – 206PubMedCrossRefGoogle Scholar
  34. Nijsten MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet ii: 921Google Scholar
  35. Noma T, Mizuta T, Rosen A, Hirano T, Kishimoto T, Honjo T (1987) Enhancement of the interleukin 2 receptr expression on T cells by multiple B-lymphotopic lymphokines. Immunol Lett 15: 249 – 253PubMedCrossRefGoogle Scholar
  36. Opp M, Obal F Jr, Cady AB, Johannsen L, Krüger JM (1989) Interleukin-6 is pyrogenic but not somnogenic. Physiol Behav 45: 1069 – 1072PubMedCrossRefGoogle Scholar
  37. Plihal W, Krug R, Pietrowsky R, Fehm HL, Born J (1996) Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 21: 513 – 523CrossRefGoogle Scholar
  38. Prange AJ, Loosen PT, Neuroff CB (1979) Peptides: application to research in nervous and mental disorders. In: Fielding S (ed) New frontier of psychotropic drug research. Futura, New YorkGoogle Scholar
  39. Reite M, Laudenslager M, Jones J, Crnic L, Kaemingk K (1987) Interferon decreases REM latency. Biol Psychiatry 22: 104 – 107PubMedCrossRefGoogle Scholar
  40. Shoham S, Davenne D, Cady AB, Dinarello CA, Kruger JM (1987) Recombinant tumor necrosis factor and interleukin-1 enhance slow-wave sleep in rabbits. Am J Physiol 253: R142 – 149PubMedGoogle Scholar
  41. Smith RA, Norris F, Palmer D, Bernhardt L, Wills RJ (1985) Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration. Clin Pharmacol Ther 37: 85 – 88PubMedCrossRefGoogle Scholar
  42. Späth-Schwalbe E, Porzsolt F, Kigel W, Born J, Kloss B, Fehm HL (1989) Elevated plasma Cortisol levels during interferon-γ treatment. Immunopharmacology 17: 141 – 145PubMedCrossRefGoogle Scholar
  43. Späth-Schwalbe E, Born J, Schrezenmeier H, Bornstein SR, Stromeyer P, Drechsler S, Fehm HL, Porzsolt F (1994) Interleukin-6 stimulates the hypothalamus-pituitary- adrenocortical axis in man. J Clin Endocrinol Metab 79: 1212 – 1214PubMedCrossRefGoogle Scholar
  44. Späth-Schwalbe E, Hansen K, Schmidt F, Bornstein S, Burger K, Fehm HL, Born J (1996) Effects of recombinant interleukin-6 in healthy men. A: Analysis of nocturnal hormone secretion and sleep after interleukin-6 administration (submitted)Google Scholar
  45. Toth LA (1995) Sleep, sleep deprivation and infectious disease: studies in animals. Adv Neuroimmunol 5: 79 – 92PubMedCrossRefGoogle Scholar
  46. Van Snick J (1990) Interleukin-6: an overview. Annu Rev Immunol 8: 253 – 278PubMedCrossRefGoogle Scholar
  47. Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartentruber DS, Ettinghausen SE, Gunn H, Mixon A, Kim H, Cole D (1993) Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11: 499 – 506PubMedGoogle Scholar
  48. Whybrow RP, Prange AJ (1981) A hypothesis of thyroid-catecholamine-receptor interaction. Arch Gen Psychiatry 38: 106 – 113PubMedGoogle Scholar
  49. Wilber JF, Utiger RD (1969) The effect of glucocorticoids on thyrotropin secretion. J Clin Invest 48: 2096 – 2103PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • J. Born
    • 1
    • 2
  • E. Späth-Schwalbe
    • 3
  1. 1.Department of Clinical NeuroendocrinologyUniversity of LuebeckFederal Republic of Germany
  2. 2.Department of Physiological PsychologyUniversity of BambergCharite, BerlinFederal Republic of Germany
  3. 3.Department of Internal MedicineHumboldt UniversityCharite, BerlinFederal Republic of Germany

Personalised recommendations